New York's OCM Battles Enforcement Challenges Amid Seed-to-Sale Lawsuit
New York's Office of Cannabis Management (OCM) is facing significant enforcement hurdles, including a dropped major recall, a halted investigation into license rentals, and a fresh lawsuit threatening its seed-to-sale tracking system rollout on January 12. These issues undermine efforts to regulate the state's cannabis market and protect public health from illicit products.
Recent Enforcement Setbacks
In December, OCM abandoned its largest recall to date and dropped a probe into an alleged license rental scheme involving Omnium Health, where licensed facilities supposedly aided unlicensed operators in producing for both legal and black markets. Governor Kathy Hochul intervened, demanding resignations from interim Executive Director Felicia Reid and Deputy Counsel James Rogers, who led the Trade Practices Bureau formed to combat illicit activity.
- OCM launched adult-use sales on December 29, 2022, but tracking deadlines have repeatedly slipped due to court delays and vendor changes.
- Originally using BioTrack for batch-level tagging, OCM switched to Metrc after a partnership announcement, now requiring individual item tags.
The Veterans Holdings Lawsuit
Licensed processor Veterans Holdings Inc., operating as Veterans Choice Creations, filed a 19-page complaint on December 16 in Albany Supreme Court, seeking a temporary restraining order against Metrc's mandatory compliance. They argue OCM overreached by mandating tags costing 10 cents each from Metrc, creating undue economic burdens—up to $2,000 for indoor crops (10,000 sq ft canopy) or $20,000 for outdoor (100,000 sq ft).
In response, OCM offered 20 million free tags to licensed processors. The state must reply by January 7, warning that delays jeopardize product authenticity and consumer safety.
Implications for Public Health and Market Stability
A robust seed-to-sale system is crucial for tracing cannabis from cultivation to sale, preventing diversion to unregulated markets rife with contaminants like pesticides or mold—risks heightened in New York's booming illicit sector. Enforcement lapses erode trust, slow licensed growth, and prolong vulnerabilities in a market launched amid high expectations but plagued by delays.
- Without tracking, schemes like facility rentals evade detection, flooding streets with unsafe products.
- Interim leader Susan Filburn pledges stability, but leadership churn signals deeper regulatory disarray.
Outlook for Cannabis Regulation
Resolving the lawsuit will test OCM's authority and commitment to evidence-based oversight. Success could stabilize the market, fostering equity and safety; failure risks further illicit dominance. As states nationwide refine cannabis frameworks, New York's struggles highlight the need for balanced enforcement that supports licensees while prioritizing public health.
